Author:
Lang Dora S. P.,Keefe Dorothy M. K.,Schultz Tim,Pearson Alan
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Aurran-Schleinitz T, Gravis G, Vittot M, Coso D, Rey J, Schiano J, et al (2005) “One Hour” rituximab infusion is safe and improves patient care and outpatient unit management. Am Soc Hematology p 4759-
2. Middleton HJ, Mollee P, Bird R, Mills AK, Marlton P, Gill D (2005) Accelerated delivery of rituximab is safe on an out-patient basis. Blood 106:Abstract 4777
3. Chiang J, Chan A, Shih V, Hee SW, Tao M, Lim ST (2010) A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center. Int J Hematol 91:826–830
4. Roche (2005) Mathera. Roche Products Pty Limited [updated 8 April 2010; cited 2010 29 July 2010]; Available from: http://www.roche-australia.com/portal/eipf/australia/au/corporate/pharmaceuticals#oncology
5. Lang SP, George C (2011) Acute Adverse reactions of rapid rituximab infusion among adult patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia. JBI Libr Syst Rev 9(1):1–37
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献